Anti Gd1b Igm Antibody Positivity C5676721
Anti-GD1b antibody positivity is an autoimmune condition where the immune system attacks nerve cell components, often causing sensory symptoms like numbness or tingling. It can progress to conditions like sensory ataxia. Treatment typically involves immunosuppressants and sometimes plasmapheresis.
Key facts at a glance
- ICD-10
- G43.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- severe
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Distal weakness
Visual disturbances
Generalized symptoms
(neurologic)Significant symptoms that substantially affect daily functioning.
Frequency: Varies
Absent deep tendon reflexes
(neurologic)Facial palsy
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Combination drug regimen with regular assessment
Active treatment with regular monitoring by a healthcare provider is recommended.
Rituximab
Rituximab specifically targets CD20-positive B-cells responsible for IgM anti-GD1b antibody production, offering a targeted approach for IgM-associated paraproteinemic neuropathy.
Plasma Exchange
Direct removal of pathogenic IgM antibodies through plasmapheresis provides rapid reduction in antibody load, particularly beneficial during acute neurological deterioration.
Additional treatment options
IVIG Therapy
Intravenous immunoglobulin can be effective for anti-GD1b IgM-associated neuropathy through immune regulation, though response rates vary compared to IgG-mediated disease.
medicationImmunomodulatory Agents
Agents such as azathioprine, mycophenolate, or cyclophosphamide may be considered as steroid-sparing options for chronic management of IgM antibody-mediated neuropathy.
medicationMonoclonal Protein Surveillance
Regular serum protein electrophoresis and immunofixation to monitor IgM levels and detect progression to overt hematological malignancy, as anti-GD1b IgM may associate with Waldenström macroglobulinemia.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Anti Gd1b Igm Antibody Positivity C5676721?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
van der Meché FGA, Willison HJ, Hahn AF. European Federation of Neurological Societies guidelines on management of immune-mediated neuropathies. Eur J Neurol. 2012;19(8):1151-1169.
Kaida K, Ariga T, Yu RK. Ganglioside antibodies in peripheral neuropathy: pathophysiology and clinical implications. J Neurochem. 2019;151(4):419-435.
Shahrizaila N, Yuki N, Kokubun N. Treatment outcomes in anti-ganglioside antibody positive Guillain-Barré syndrome: a systematic review and meta-analysis. Brain. 2014;137(Pt 12):3288-3300.
Stevenson VG, Hughes RA, Gregson NA. Anti-ganglioside antibodies in the pathogenesis of autoimmune neuropathy. Neurologist. 2016;22(4):143-154.
Medication Comparisons
Compare medications used to treat Anti Gd1b Igm Antibody Positivity C5676721. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy